StageZero Life Sciences Ltd.
StageZero Life Sciences Ltd. (SZLSF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SZLSF · as of Jun 15, 2026
Key Statistics
Explore StageZero Life Sciences Ltd. Data
szlsf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
szlsf competitorsSZLSF
CNNA
ENZC
EPGNF
EXMT
IDTAStock Performance
Full HistoryAbout StageZero Life Sciences Ltd.
StageZero Life Sciences Ltd. is a vertically integrated healthcare enterprise focused on the development and commercialization of proprietary molecular diagnostic tests. These tests are primarily desi…
what is stagezero life sciences ltd. · szlsf stock overview · stagezero life sciences ltd. company profile · who is stagezero life sciences ltd. ceo · szlsf OTC · stagezero life sciences ltd. headquarters · stagezero life sciences ltd. business segments
About Stock Overview & Key Data
StageZero Life Sciences Ltd. (SZLSF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Sep 8, 2009. As of the latest trading session, SZLSF stock price is $0.01, with a market capitalization of $630,018. The stock has returned -82.22% over the past 12 months and +920.00% year-to-date.
In fiscal year 2022, StageZero Life Sciences Ltd. reported revenue of $3.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, StageZero Life Sciences Ltd. (SZLSF) stock price is $0.01. The stock is traded on OTC under the ticker symbol SZLSF. The 52-week range is $0.00 – $0.03.